BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  John Chiminski, Former Catalent Chair and CEO, to Serve as CD&R Operating Advisor

  July 7, 2026

   · 

  2 min read
• Press Releases

  Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases

  July 7, 2026

   · 

  5 min read
• Press Releases

  Altesa BioSciences Announces Upcoming Oral Presentation Featuring Novel Vapendavir Data at European Respiratory Society International Congress 2026

  July 7, 2026

   · 

  3 min read
• Press Releases

  Clinical Study Shows Xpert® Xpress MVP Delivers Appropriate Treatment More Often to Women with Vaginal Symptoms

  July 7, 2026

   · 

  5 min read
• Press Releases

  Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

  July 7, 2026

   · 

  1 min read
• Press Releases

  Emmecell Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EO2002 for the Treatment of Corneal Endothelial Disease

  July 7, 2026

   · 

  2 min read
• Press Releases

  NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

  July 7, 2026

   · 

  1 min read
• Press Releases

  Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND

  July 7, 2026

   · 

  5 min read
• Press Releases

  Molecular Targeting Technologies Presents First Clinical Validation of the Evans Blue Platform, Demonstrating Up to 15-Day Tumor Retention Using Approximately 12.5% of the Radioactivity Required for Conventional PRRT

  July 7, 2026

   · 

  5 min read
• 

  Cancer

  BMS’ Krazati kneels to chemo in confirmatory colorectal cancer trial

  Patients treated with Bristol Myers Squibb’s Krazati in combination with cetuximab saw shorter median overall and progression-free survival than comparators on chemotherapy.

  July 7, 2026

   · 

  2 min read

   · 

  Tristan Manalac